Osteosarcoma-Reference-Cited by-同舟云学术

Osteosarcoma

Published:2022-12-08 Issue:1 Volume:8 Page:
ISSN:2056-676X
Container-title:Nature Reviews Disease Primers
language:en
Short-container-title:Nat Rev Dis Primers

Author:

Beird Hannah C.^ORCID,Bielack Stefan S.,Flanagan Adrienne M.,Gill Jonathan^ORCID,Heymann Dominique^ORCID,Janeway Katherine A.,Livingston J. Andrew,Roberts Ryan D.,Strauss Sandra J.,Gorlick Richard^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://www.nature.com/articles/s41572-022-00409-y.pdf

Reference235 articles.

1. Mirabello, L., Troisi, R. J. & Savage, S. A. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer 115, 1531–1543 (2009).

2. Bielack, S. S. et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 20, 776–790 (2002). A study that affirms tumour site and size, primary metastases, response to chemotherapy, and surgical remission as independent prognostic factors in patients with osteosarcoma.

3. Klein, M. J. & Siegal, G. P. Osteosarcoma: anatomic and histologic variants. Am. J. Clin. Pathol. 125, 555–581 (2006).

4. Piperdi, S. et al. β-Catenin does not confer tumorigenicity when introduced into partially transformed human mesenchymal stem cells. Sarcoma 2012, 164803 (2012).

5. Bertoni, F. & Bacchini, P. Classification of bone tumors. Eur. J. Radiol. 27 (Suppl. 1), S74–S76 (1998).

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eurycomanone inhibits osteosarcoma growth and metastasis by suppressing GRP78 expression;Journal of Ethnopharmacology;2024-12

2. Biomedical applications of NIR-II organic small molecule fluorescent probes in different organs;Coordination Chemistry Reviews;2024-11

3. DNA Damage-Sensitized metal phenolic nanosynergists potentiate Low-Power phototherapy for osteosarcoma therapy;Journal of Colloid and Interface Science;2024-11

4. Identification of a biomarker to predict doxorubicin/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimens;Translational Oncology;2024-11

5. Advanced tumor organoid bioprinting strategy for oncology research;Materials Today Bio;2024-10